16th place on the Forbes’ list as one the best Russian pharmaceutical companies (according to the Forbes rating, September 2021)
TOP-5 Russian manufacturers in terms of sales growth rates (according to the AlphaRM results, September 2022)
2-time winner of the «Platinum Ounce» pharmaceutical award. Category: «Dynamics of the Year»
№1 product on the osteoarthritis treatment market – Armaviscon
CPhI Awards nominee 2018. Category: «Excellence in Pharma: OTC»
TOP-6 of the fastest growing pharmaceutical companies: annual growth rate is 42% (AlphaRM, September 2022)
Angidak is the winner of the «Green Cross» award. «The drug of choice for the sore throat treatment», August 2022
Mestamidin-nasal is the most successful launch in 2021-2022 (according to the Ipsos results, September 2022)
The TOP 10 finalist of the Award «Fontanka.ru: Recognition and Influence» (2023) in the nominations «Made in St. Petersburg and Leningrad Region» and «Employer of the Year»
№1 in terms of growth rate of medical prescriptions (Ipsos, Q1 23-Q2 22)
Solopharm has received several awards at once at the Smartpharma® Awards 2023
IQ Provision project - №1 in the following nomination: «Informative and outreach project for pharmacy workers»
Gylan Comfort - №2 in the following nomination: «Artificial tear agent with hyaluronic acid in high concentration»
DeTriFerol - №2 in the nomination: «Vitamin D3 source for children from the first year of life»
LinAqua Soft - №3 in the nomination: «Nasal cavity care product»
Solopharm is included in the list of strategic enterprises
At the end of April 2023 Solopharm successfully launched two new production centers at its liquid dosage forms and food supplements plants
Solopharm has opened new doors - Matrix Wall (own production site for design, manufacture, and installation of clean rooms)
№1 in the ranking of manufacturers in the target market (According to Ipsos, March 2024, data on medical prescriptions, us + competitors)
TOP-3 in the ranking of domestic manufacturers (According to Ipsos, March 2024, data on medical prescriptions, production is localized in the Russian Federation)
Angidak® - the drug of choice for the «mountain» first aid kit for sore throat treatment («Pharmacology of Mountains» project)
TOP-10 manufacturers in the retail segment (According to AlphaRM, 3 months 2024)
TOP-10 leading companies in digital promotion (According to Ipsos, 2023 vs 2022)
6th place in the «Local manufacturing companies» nomination ("Bionika Media Innovations", publishing house, according to the leaders of the influence rating 2023)
№1 in the ophthalmic market segment in value terms (According to IQVIA and DSM Group, 2023, retail (Medical devices + Drugs)
№1 in the recommendations of ophthalmologists of Russia (According to Ipsos Prindex, Q1 2024)
№1 in the recommendations of otorhinolaryngologists of Russia (According to Ipsos Prindex, Q1 2024)
№5 in the recommendations of pediatricians of Russia (According to Ipsos Prindex, Q1 2024)
№8 in Russia by turnover in rubles and packs in the OTC segment (According to AlphaRM, in January-May 2024, dated in June 2024)
Olyfrin is №1 drug recommended by pediatricians and ENT doctors for the treatment and protection of nasal mucosa
Tramycent is №1 in the ENT doctors’ prescriptions for the treatment of complicated rhinitis
The TOP 10 finalist of the Award «Fontanka.ru: Recognition and Influence» (2024) in the nomination «Made in St. Petersburg and Leningrad Region»
Belarus
Azerbaijan
Armenia
Vietnam
Georgia
Kyrgyzstan
Tajikistan
Kazakhstan
Cambodia
Uzbekistan
Morocco
Mongolia
Qatar
Kuwait
